Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)

April 20, 2026 6:35 AM EDT Send to a Friend
H.C. Wainwright analyst Mitchell S. Kapoor reiterated a Buy rating and $50.00 price target on Legend Biotech Corp. (NASDAQ: LEGN).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login